Karuna Therapeutics, Inc. Proceeds from Stock Options Exercised
Karuna Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $51.38 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-02-22
- Karuna Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2023-12-31 was $24.33M, a 348.55% increase year-over-year.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2023-09-30 was $2.86M, a 88.61% decline year-over-year.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2023-06-30 was $18.61M, a 272.90% increase year-over-year.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2023-03-31 was $5.57M, a 334.40% increase year-over-year.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for fiscal 2023 was $51.38M, a 39.46% increase from fiscal 2022.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for fiscal 2022 was $36.84M, a 384.27% increase from fiscal 2021.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for fiscal 2021 was $7.61M, a 85.65% increase from fiscal 2020.
- Karuna Therapeutics, Inc. proceeds from stock options exercised for fiscal 2020 was $4.10M, a 102350.00% increase from fiscal 2019.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-12-31 | $24.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $27.20M derived: sum of 2 quarters · filed 2024-02-22 | $45.81M derived: sum of 3 quarters · filed 2024-02-22 | $51.38M 10-K · filed 2024-02-22 |
| 2023-09-30 | $2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $21.48M derived: sum of 2 quarters · filed 2023-11-02 | $27.05M 10-Q · filed 2023-11-02 | $32.47M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | $18.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $24.18M 10-Q · filed 2023-08-03 | $29.61M derived: sum of 3 quarters · filed 2024-02-22 | $54.75M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | $5.57M 10-Q · filed 2023-05-04 | $10.99M derived: sum of 2 quarters · filed 2024-02-22 | $36.14M derived: sum of 3 quarters · filed 2024-02-22 | $41.13M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $30.57M derived: sum of 2 quarters · filed 2024-02-22 | $35.56M derived: sum of 3 quarters · filed 2024-02-22 | $36.84M 10-K · filed 2024-02-22 |
| 2022-09-30 | $25.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $30.14M derived: sum of 2 quarters · filed 2023-11-02 | $31.42M 10-Q · filed 2023-11-02 | $35.22M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.27M 10-Q · filed 2023-08-03 | $10.07M derived: sum of 3 quarters · filed 2024-02-22 | $10.82M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $1.28M 10-Q · filed 2023-05-04 | $5.08M derived: sum of 2 quarters · filed 2024-02-22 | $5.83M derived: sum of 3 quarters · filed 2024-02-22 | $8.22M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $4.55M derived: sum of 2 quarters · filed 2024-02-22 | $6.94M derived: sum of 3 quarters · filed 2024-02-22 | $7.61M 10-K · filed 2024-02-22 |
| 2021-09-30 | $749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.14M derived: sum of 2 quarters · filed 2022-11-03 | $3.81M 10-Q · filed 2022-11-03 | $5.35M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.06M 10-Q · filed 2022-08-08 | $4.60M derived: sum of 3 quarters · filed 2023-02-23 | $5.28M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $671.00K 10-Q · filed 2022-05-05 | $2.22M derived: sum of 2 quarters · filed 2023-02-23 | $2.90M derived: sum of 3 quarters · filed 2023-02-23 | $4.25M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.23M derived: sum of 2 quarters · filed 2023-02-23 | $3.58M derived: sum of 3 quarters · filed 2023-02-23 | $4.10M 10-K · filed 2023-02-23 |
| 2020-09-30 | $680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.04M derived: sum of 2 quarters · filed 2021-11-04 | $2.55M 10-Q · filed 2021-11-04 | $2.55M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.87M 10-Q · filed 2021-08-05 | $1.87M derived: sum of 3 quarters · filed 2022-02-24 | $1.87M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $517.00K 10-Q · filed 2021-05-06 | $517.00K derived: sum of 2 quarters · filed 2022-02-24 | $517.00K derived: sum of 3 quarters · filed 2022-02-24 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $4.00K 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $4.00K 10-Q · filed 2020-08-05 |